It aims to improve access to COVID-19-related quality and affordable diagnostic and therapeutic tools in 5 countries through policy and regulatory support, technical support to ministries of health, supply chain and procurement assistance, and demand generation in communities.
During grant implementation, evidence will be generated to support scale-up and further catalytic uptake in existing countries and beyond.
-Changes to a less virulent strain & reduced focus from countries
-Reduced country focus on C19
-MoH reprioritization and deployment of limited resources
Did you know there are medications available to prevent and treat COVID-19? If you are at high risk for severe SARS-CoV-2 infection, it’s important that you access these treatments as soon as possible. We have everything you need to know about COVID-19, including information on symptoms, testing, vaccines, treatments, variants, the latest research, tools and training material for healthcare workers and providers as well as case studies available in one place.